The Claim
Daily supplementation with 180 µg of menaquinone-7 for one year reduces plasma levels of dephosphorylated-undercarboxylated matrix Gla protein (dp-ucMGP) by 13.4% in post-menopausal women.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking 180 micrograms of menaquinone-7 every day for one year lowers the level of dephosphorylated-undercarboxylated matrix Gla protein in the blood by 13.4% in post-menopausal women.
See the scientific wording
Daily 180 µg menaquinone-7 supplementation for one year significantly reduces plasma levels of dephosphorylated-undercarboxylated matrix Gla protein (dp-ucMGP) by 13.4% in post-menopausal women, indicating enhanced activation of this vascular protective protein.
Vitamin K2 from the supplement activates a protein in blood vessel walls that grabs calcium and stops it from building up in the arteries. This keeps the arteries flexible and prevents them from hardening.
What the research says
1 studyTaking a daily vitamin K2 supplement (180 micrograms) for a year lowered a specific blood marker linked to stiff arteries by 13.4% in post-menopausal women, meaning their bodies became better at activating a protein that protects their blood vessels.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.